Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease c syndrome
Phenotype |obesity
Sentences 377
PubMedID- 24071981 In recent years the literature has shown an increasing interest in paediatric obesity and the onset of diabetes and the metabolic syndrome in adulthood.
PubMedID- 24816278 Hepatic manifestations of the metabolic syndrome (hmms) are associated with obesity, type 2 diabetes/insulin resistance, non-alcoholic fatty liver disease (nafld), and progression to non-alcoholic steatohepatitis (nash) [1].
PubMedID- 26379783 The objective of this study was to determine whether severe obesity in women with metabolic syndrome leads to functional remodeling of arterial wall and change in the corresponding markers.
PubMedID- 21593202 obesity is the hallmark of the metabolic syndrome and represents a major global health problem that frequently associates with the development of chronic diseases, including type 2 diabetes and cardiovascular disease (1).
PubMedID- 20514047 In this regard the ability of adipose tissue to expand and match the storage needs of energy surplus may be a key determinant of the susceptibility to developing metabolic syndrome associated with obesity (1-4).
PubMedID- 22694047 The prevalence of the metabolic syndrome with attendant morbid obesity continues to increase nationwide.
PubMedID- 22723994 Some hypothesized that sua mediates obesity and other features of metabolic syndrome by reducing endothelial nitric oxide and decreasing insulin-mediated glucose uptake in skeletal muscle [8].
PubMedID- 24205128 Nafld is a common feature of metabolic syndrome being often associated with obesity, dyslipidemia and diabetes and mostly closely linked to insulin resistance.
PubMedID- 26024889 Several cardiovascular risk factors are known to affect platelet aggregation in healthy individuals including age, sex, obesity, and the presence of metabolic syndrome [6–10].
PubMedID- 25659889 Peripheral insulin resistance is a key component of metabolic syndrome associated with obesity, dyslipidemia, hypertension, and type 2 diabetes.
PubMedID- 26183621 As pparγ is a significant drug target for metabolic syndrome associated with obesity-induced insulin resistance and hyperglycemia3132, we used the db/db diabetic mouse model and their littermates to determine whether chelerythrine has the ability to improve glucose homeostasis in these mice.
PubMedID- 21834955 The relationship between depression and waist circumference or abdominal obesity as a component of metabolic syndrome has been explored previously in studies examining the associations of metabolic syndrome with mental illness [39-43].
PubMedID- 26063458 Metabolic syndrome is linked with obesity and is often first identified clinically by elevated bmi and elevated levels of fasting blood glucose that are generally secondary to insulin resistance.
PubMedID- 22392186 In this study, we sought to assess the association between brachial artery fmd, high-sensitive c-reactive protein (hs-crp) and cardiovascular risk factors including obesity in patients with cardiac syndrome x.
PubMedID- 25755863 Methods: total of 94 patients were divided into obesity with metabolic syndrome (ms) (n=30), obesity without ms (n=33), and control (n=31) groups.
PubMedID- 21176200 Results from the multiple regression analysis showed that insulin resistance and obesity were associated with the metabolic syndrome.
PubMedID- PMC4055882 Erα undoubtedly plays a role in the estrogenic reduction in ingestive behavior—as evidenced by the fact that the erα agonist ppt decreases food intake and meal size in ovariectomized rats [45], and erα silencing in the vmn results in obesity associated with metabolic syndrome [46].
PubMedID- 26064924 Young rats that received the cafeteria diet for 8 weeks developed metabolic syndrome along with obesity, higher hepatic weight, increased plasma levels of glucose, insulin and triglycerides, and insulin resistance [57].
PubMedID- 22937748 Reported cutoff points for waist circumference and their predictive value for abdominal obesity and risk of metabolic syndrome (mets) in the chinese population [13].
PubMedID- 20835560 Da-paz-filho et al.13 described a decrease in leptin production by adipose tissue in obesity associated with severe metabolic syndrome, suggesting a state of relative leptin deficiency in obesity that is associated with advanced stages of the syndrome.
PubMedID- 24847618 Background: obesity-induced metabolic syndrome is a multiple risk factor for cardiovascular (cv) risk factors and type 2 diabetes, and ethnic minorities seem to have unfavourable medical risk factors in general more frequently than majority populations.
PubMedID- 26092037 These include obesity and components of metabolic syndrome, with the specific systems affected determined by the type and timing of developmental exposure.
PubMedID- 23515973 The great increase in type 2 diabetes has been due to environmental changes, many of which have resulted in obesity associated with the metabolic syndrome and all of its consequences.
PubMedID- 21645344 It has become clear that obesity and features of the metabolic syndrome, which encompass glucose dysregulation, dyslipidemia and hypertension, are key risk factors for the development and progression of nafld [1].
PubMedID- 25527815 Background: obesity is the hallmark of the metabolic syndrome representing a major global health problem.
PubMedID- 25591987 Taken together, it is clear that baff unites obesity with metabolic syndrome.
PubMedID- 26213922 Indeed, inheritance-oriented investigations concerning gene-nutrient interactions on energy homeostasis processes and metabolic cell functions are extending to all clinically chronic relevant diseases, such as type 2 diabetes, cardiovascular events, obesity and associated features of metabolic syndrome.
PubMedID- 26016481 Nzo/hlltj is a common laboratory strain used as a model of metabolic syndrome because of its extreme obesity and hyperglycemic phenotype [84].
PubMedID- 23435016 In mice, a two to three-fold elevation of 11β-hsd1 selectively in adipose tissue phenocopies the metabolic syndrome, with central obesity, insulin resistance, dyslipidaemia and hypertension [115,116] whereas similar transgenic expression of 11β-hsd2 in adipocytes (it is not normally expressed in adipocytes), presumably lowering intra-adipose glucocorticoid action, causes insulin sensitisation in high fat fed mice [117].
PubMedID- 23648313 obesity is closely associated with the metabolic syndrome (mets) and subsequent low-grade inflammation links to endothelial dysfunction (ed) and cardiovascular disease.
PubMedID- 23460844 The abdominal obesity component of the metabolic syndrome was not adjusted by bmi.
PubMedID- 23949560 This attenuation may arise from causal biological correlations between insulin sensitivity, obesity, and clinical definitions of metabolic syndrome.
PubMedID- 25621503 It is well known that an increase in adipokine production can influence glucose metabolism, insulin sensitivity and inflammation, and this finding could represent a molecular link between obesity and the development of diabetes mellitus, metabolic syndromes and cardiovascular diseases [77].
PubMedID- 23696677 Some studies have suggested that the metabolic syndrome (including obesity) may be associated with dkd in type 1 diabetes.
PubMedID- 24111227 Ultrasonography-based visceral fat estimation is a promising method to assess central obesity, which is associated with metabolic syndrome.
PubMedID- 19863955 Background: in obese patients, positioning of the bioenterics intragastric balloon (bib) proved beneficial for weight loss, but the effect of the device on ameliorating some components of the metabolic syndrome associated with obesity remains uncertain.
PubMedID- 23805900 Associations of cardiorespiratory fitness, physical activity, and obesity with metabolic syndrome in hong kong chinese midlife women.
PubMedID- 24270951 These transitional nutrition regions are very relevant to this type of research because these areas contain a large number of children with low birth weights who are further exposed to diets containing foods of low cost, high caloric value, and low nutrient quality, which may increase the incidence of obesity and diseases associated with metabolic syndrome (9).
PubMedID- 23819808 Background: it has been well documented that obesity is closely associated with metabolic syndrome (mets).
PubMedID- 24396679 The crucial components that may link abdominal obesity to other features of the metabolic syndrome and end-organ damage are presumably the presence of insulin resistance and elevated insulin levels, increased inflammation with macrophage infiltration in fat tissues with concomitant release of proinflammatory cytokines, and endothelial dysfunction, which all may lead to sht.
PubMedID- 22777542 According to skilton et al.,35 adjusting for bmi, in this case, will produce findings that address the association between macronutrient composition and the non-obesity components of the metabolic syndrome.
PubMedID- 25922847 Thus, the ability of adipose tissue to expand and match the storage needs of energy surplus may be a key determinant in protection against the metabolic syndrome associated with obesity [72].
PubMedID- 23354399 Cardiometabolic syndrome occurs with obesity and consists of pathophysiological factors that increase the risk for cardiovascular events.
PubMedID- 24489111 High-fat diet is considered to be one of the main stressors that can induce negative effects in animals such as metabolic syndrome with obesity, insulin resistance, and fatty liver.
PubMedID- 26110103 obesity is closely associated with metabolic syndrome, type 2 diabetes mellitus (t2dm) and cardiovascular diseases.
PubMedID- 22691241 Logistic regression (backward selection) was further performed to calculate odds ratios (ors) for high versus low homa-ir according to demographic and lifestyle (gender, age, tobacco use), metabolic (obesity, hypertension, use of statins, metabolic syndrome), and clinical parameters, including the das28, health assessment questionnaire (haq), crp, and ra treatment modality (glucocorticoids, methotrexate).
PubMedID- 23930111 Background: obesity in accordance with metabolic syndrome (mets) confronts populations at the higher risk of morbidity and mortality of chronic diseases including, chronic kidney diseases (ckd).
PubMedID- 22396222 Taken together, these findings indicate that inhibiting adipogenic differentiation of hamscs by artemisinic acid occurs primarily through reduced expression of c/ebp delta, which is mediated by the inhibition of jnk and suggest that aremisinic acid may be used as a complementary treatment option for obesity associated with metabolic syndrome.
PubMedID- 22809366 In addition, fatty liver is a manifestation of metabolic syndrome, and is associated with obesity, type 2 diabetes mellitus (t2dm), and hypertriglyceridemia [11].
PubMedID- 23714599 Background: opinions differ over the exercise modalities that best limit cardiovascular risk (cvr) resulting from visceral obesity in individuals with metabolic syndrome (mets).

Page: 1 2 3 4 5 6 7 8